Venous Thromboembolism
Latest News
Study Finds No Increased MACE Risk for JAK Inhibitors in Patients With Atopic Dermatitis
The analysis looked at treatment with the upadacitinib and abrocitinib (Cibinqo), both approved for treating AD in...
Commentary
On Second Thought: Aspirin for Primary Prevention — What We Really Know
Recommendations vis-à-vis aspirin have evolved at a dizzying pace.
Latest News
‘Door-to-Thrombectomy’ Time for Acute PE Linked to Better Outcomes
Faster treatment with mechanical thrombectomy for patients with PE leads to better outcomes, research finds.
Latest News
Use of SGLT2 Inhibitors Associated With Better Survival in PAH
SGLT2i use improved both short- and long-term survival for those with PAH, study finds.
From the Journals
Current Hydroxychloroquine Use in Lupus May Provide Protection Against Cardiovascular Events
Hydroxychloroquine demonstrated protective effects against cardiovascular events in patients with systemic lupus erythematosus.
Conference Coverage
Excess Thrombotic Risk in RA Has No Clear Driving Factor
Irrespective of age, duration of disease, and other factors, people with rheumatoid arthritis have a consistently higher risk for venous...
Latest News
Review Finds No Short-term MACE, VTE risk with JAK Inhibitors For Dermatoses
Meta-analysis suggests short-term use does not increase cardiovascular or thrombotic risk in people being treated for dermatological conditions....
Commentary
Do Statins Offset Venous Thrombosis Risk With Hormone Therapy?
Is statin therapy able to offset some of the excess risk for VTE among women taking menopausal hormone therapy?
Conference Coverage
Pregnancy in rheumatic disease quadruples risk of cardiovascular events
Pregnant patients with lupus and concomitant APS had an 18-fold higher risk for a cardiovascular event during and up to 6 weeks postpartum than...
Latest News
Review finds no CV or VTE risk signal with use of JAK inhibitors for skin indications
Of the 35 trials studied, most involved patients with atopic dermatitis.
From the Journals
Supplemental oxygen fails to improve echocardiographic measures in PE patients
The proportions of patients with normalized RV/LV ratios were similar with and without supplemental oxygen.